C.jeikeium, Aminoglycoside & Class A (blaPER/VEB/GES) resistance Multiplex

Cat no. YSL-qPX-EC-CJ.AM.CA-100

C.jeikeium, Aminoglycoside & Class A (blaPER/VEB/GES) resistance Multiplex

Cat no. YSL-qPX-EC-CJ.AM.CA-100

A multiplex qPCR kit for the detection of C.jeikeium, Aminoglycoside & Class A (blaPER/VEB/GES) resistance

Corynebacterium jeikeium is a bacterium known for its aminoglycoside and Class A beta-lactamase resistance. It can cause infections in immunocompromised patients, leading to conditions such as bloodstream infections and skin abscesses. Detection of this pathogen is crucial in healthcare settings to prevent the spread of antibiotic resistance and ensure proper treatment of infected individuals.

YouSeq's qPCR kit to detect Corynebacterium jeikeium allows for sensitive and specific identification of this pathogen, enabling early intervention and appropriate management of infections. Timely detection of this target is essential to prevent antibiotic resistance and improve patient outcomes in healthcare settings.

United States FlagAvailable for delivery in United States

Price on enquiry

Order now

For Research Use Only. Not intended for diagnostic use.

Contents


Target specific primer/probe mix, including endogenous control
qPCR MasterMix
Positive control template
DNase/RNase free water
Template resuspension buffer

Technical specification


Target Gene(s):upstream of tRNA-Met gene,Control gene
Efficiency: 90-110%
Sensitivity: <100 copy detection
Run Time: Approx 1hr30 (dependent on instrumentation)

Product variants


YSL-qPX-EC-CJ.AM.CA-100 : Lyophilised version for ambient shipping
YS-qPX-EC-CJ.AM.CA-100 : Frozen version for dry ice shipping

Pseudonyms

C. jejuni; Campylobacter; C. jejikeium; AMG; Aminoglycoside; BLAPER; VEB; GES; Pseudomonas aeruginosa; nosocomial infection; multi-drug resistant pathogen; CLASS A resistance; MDR pathogens; coli; Acinetobacter baumannii; Klebsiella pneumoniae; Enterobacter cloacae; Serratia marcescens; Pseudomonas species; ESBL; extended-spectrum beta-lactamase; carbapenem-resistant Enterobacteriaceae (CRE); superbug; hospital-acquired infection; gram-negative bacteria; cephalosporin-resistant pathogens; multidrug-resistance;MDR-CJ; MDR-GNB; MDRPA; MDR-KP; MDR-SA; MDR-EC; MDR-SM; MDR-AB; MDR-Acinetobacter; MDR-Klebsiella; MDR-Pseudomonas; MDR-Enterobacter; MDR-Serratia;; ; ; ;

Related products

More products

Still scrolling? We love adventurers

We work at the cutting edge of molecular biology, striving to disrupt our industry. We drive continuous product innovation and we aren’t afraid to take on new challenges.

More about us

Related learning resources